Company Presentation

Leman Biotech Lausanne SA

Category:Emerging Biotech Company
Time:15:45 – 16:00
Speaker:Karthik Sathiyanadan, Director, Translational Research

Company profile

Leman Biotech SA, a clinical-stage EPFL spin-off co-founded by Prof. Li Tang, focuses on developing novel metabolic cancer immunotherapies. Headquartered in Shenzhen, China, its R&D pipelines include metabolism-enhanced CAR-T cell therapy and biomacromolecule drugs. The company recently initiated IIT clinical trials for its innovative metabolically armed CAR-T therapy. With US$18M in angel financing, Leman Biotech is well-positioned to expand the clinical development of its pipeline.

Follow us